Literature DB >> 21961981

Consolidation of hepatic arterial inflow by embolization of variant hepatic arteries in preparation for yttrium-90 radioembolization.

Mohamed H K Abdelmaksoud1, John D Louie, Nishita Kothary, Gloria L Hwang, William T Kuo, Lawrence V Hofmann, David M Hovsepian, Daniel Y Sze.   

Abstract

PURPOSE: Before yttrium-90 ((90)Y) radioembolization administration, the authors consolidated arterial inflow by embolizing variant hepatic arteries (HAs) to make microsphere delivery simpler and safer. The present study reviews the technical and clinical success of these consolidation procedures.
MATERIALS AND METHODS: Preparatory and treatment angiograms were retrospectively analyzed for 201 patients. Variant HAs were coil-embolized during preparatory angiography to simplify arterial anatomy. Collateral arterial perfusion of territories previously supplied by variant HAs was evaluated by digital subtraction angiography (DSA), C-arm computed tomography (CT), and technetium-99m ((99m)Tc)-macroaggregated albumin (MAA) scintigraphy, and by follow-up evaluation of regional tumor response.
RESULTS: A total of 47 variant HAs were embolized in 43 patients. After embolization of variant HAs, cross-perfusion into the embolized territory was depicted by DSA and by C-arm CT in 100% of patients and by (99m)Tc-MAA scintigraphy in 92.7%. Uniform progressive disease prevented evaluation in 33% of patients, but regional tumor response in patients who responded supported successful delivery of microspheres to the embolized territories in 95.5% of evaluable patients.
CONCLUSIONS: Embolization of variant HAs for consolidation of hepatic supply in preparation for (90)Y radioembolization promotes treatment of affected territories via intrahepatic collateral channels.
Copyright © 2011 SIR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21961981     DOI: 10.1016/j.jvir.2011.06.014

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  13 in total

1.  Radioembolization with 90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: final report of a prospective pilot study.

Authors:  Nicholas Fidelman; Robert K Kerlan; Randall A Hawkins; Miguel Pampaloni; Andrew G Taylor; Maureen P Kohi; K Pallav Kolli; Chloe E Atreya; Emily K Bergsland; R Kate Kelley; Andrew H Ko; W Michael Korn; Katherine Van Loon; Ryan M McWhirter; Jennifer Luan; Curt Johanson; Alan P Venook
Journal:  J Gastrointest Oncol       Date:  2016-12

Review 2.  Multiple arteries supplying a single tumor vascular distribution: microsphere administration options for the interventional radiologist performing radioembolization.

Authors:  Charles E Ray; Ron C Gaba; Martha-Gracia Knuttinen; Jeet Minocha; James T Bui
Journal:  Semin Intervent Radiol       Date:  2014-06       Impact factor: 1.513

Review 3.  Intra-arterial therapies for metastatic colorectal cancer.

Authors:  David S Wang; John D Louie; Daniel Y Sze
Journal:  Semin Intervent Radiol       Date:  2013-03       Impact factor: 1.513

4.  90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: a pilot study.

Authors:  Nicholas Fidelman; Robert K Kerlan; Randall A Hawkins; Andrew G Taylor; Maureen P Kohi; K Pallav Kolli; Emily K Bergsland; R Kate Kelley; Andrew H Ko; W Michael Korn; Ryan M McWhirter; Jennifer Luan; Alan P Venook
Journal:  J Gastrointest Cancer       Date:  2014-06

5.  Embolization of variant hepatic arteries in patients undergoing percutaneous hepatic perfusion for unresectable liver metastases from ocular melanoma.

Authors:  T Susanna Meijer; Lioe-Fee de Geus-Oei; Christian H Martini; Fred G J Tijl; M Elske Sitsen; Arian R van Erkel; Rutger W van der Meer; Ellen Kapiteijn; Alexander L Vahrmeijer; Mark C Burgmans
Journal:  Diagn Interv Radiol       Date:  2019-11       Impact factor: 2.630

Review 6.  A Rare Anatomic Variant of Double Replaced Hepatic Arteries: A Case Report and Brief Review of the Anomalous Hepatic Vasculature Literature.

Authors:  Mazzin Elsamaloty; Eric Schupp; Abdighani Ismail; Clariza Borile; Krista Chun; Jeffrey M Sutton
Journal:  Am J Case Rep       Date:  2021-05-09

7.  Liver CT for vascular mapping during radioembolisation workup: comparison of an early and late arterial phase protocol.

Authors:  Andor F van den Hoven; Manon N G J A Braat; Jip F Prince; Pieter J van Doormaal; Maarten S van Leeuwen; Marnix G E H Lam; Maurice A A J van den Bosch
Journal:  Eur Radiol       Date:  2016-04-23       Impact factor: 5.315

8.  Prospective Clinical and Pharmacological Evaluation of the Delcath System's Second-Generation (GEN2) Hemofiltration System in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan.

Authors:  Eleonora M de Leede; Mark C Burgmans; T Susanna Meijer; Christian H Martini; Fred G J Tijl; Jaap Vuyk; Arian R van Erkel; Cornelis J H van der Velde; Ellen Kapiteijn; Alexander L Vahrmeijer
Journal:  Cardiovasc Intervent Radiol       Date:  2017-04-27       Impact factor: 2.740

9.  Celiac artery stenting to facilitate hepatic yttrium-90 radioembolization therapy.

Authors:  Murthy R Chamarthy; Terence W Hughes; Mohit Gupta; Josephina A Vossen; Noel B Velasco; Kenneth M Zinn
Journal:  Case Rep Radiol       Date:  2012-12-06

10.  Single-Institution Experience with Selective Internal Radiation Therapy (SIRT) for the Treatment of Primary and Secondary Hepatic Tumors.

Authors:  Kabalan Yammine; Francois Kamar; Jason Nasser; Claude Tayar; Marwan Ghosn; Feras Chehade; Jihad Daher; Gregory Nicolas
Journal:  Cureus       Date:  2020-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.